No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Dow Edges Higher; AT&T Posts Upbeat Earnings
Veru Shares Tumble Despite Enobosarm's Lean Muscle Preservation Breakthrough
Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December
Veru Down 46% Despite Data for Drug Preserving Lean Body Mass in Wegovy Users
Express News | Veru: Enobosarm Cut Proportion of Patients That Lost Clinically Significant Physical Function Vs Those on Wegovy Alone
Veru Reports Results From Phase 2b Trial of Enobosarm for Muscle Preservation in Weight Loss Patients